1
Hannay Mike, Schacht Dietrich Wilhelm, Wolff Hans Michael: Improved transdermal delivery system for the administration of rotigotine. Schwarz Pharma, HOFFMANN EITLE, February 12, 2004: WO/2004/012730 (6 worldwide citation)

An improved Transdermal Delivery System (TDS) comprising a backing layer inert to the components of the matrix, a self-adhesive matrix containing rotigotine and a protective foil or sheet to be removed prior to use, characterized in that the self-adhesive matrix consists of a solid or semi-solid sem ...


2
Dietrich Wilhelm Schacht, Mike Hannay, Hans Michael Wolff: Transdermal delivery system for the administration of rotigotine. UCB Pharma, Harness Dickey & Pierce, December 31, 2013: US08617591 (5 worldwide citation)

An improved Transdermal Delivery System (TDS) comprising a backing layer inert to the components of the matrix, a self-adhesive matrix containing rotigotine and a protective foil or sheet to be removed prior to use, characterized in that the self-adhesive matrix consists of a solid or semi-solid sem ...


3
Dietrich Wilhelm Schacht, Mike Hannay, Hans Michael Wolff: Transdermal delivery system for the administration of rotigotine. UCB Pharma, Harness Dickey & Pierce, August 21, 2012: US08246979 (2 worldwide citation)

An improved transdermal delivery system (TDS) comprises a self-adhesive matrix comprising a solid or semi-solid semi-permeable polymer which contains rotigotine in its free base form as a multitude of microreservoirs within the matrix. The self-adhesive matrix is highly permeable to the free base of ...


4
Hannay Mike, Schacht Dietrich W, Wolff Hans Michael: Improved transdermal delivery system for the administration of rotigotine. Sanol Arznei Schwarz, February 4, 2004: EP1386605-A1 (1 worldwide citation)

An improved Transdermal Delivery System (TDS) comprising a backing layer inert to the components of the matrix, a self-adhesive matrix containing rotigotine and a protective foil or sheet to be removed prior to use, characterized in that the self-adhesive matrix consists of a solid or semi-solid sem ...


5

6
Dietrich Wilhelm Schacht, Mike Hannay, Hans Michael Wolff: Transdermal delivery system for the administration of rotigotine. Nath & Associates, April 14, 2005: US20050079206-A1

An improved Transdermal Delivery System (TDS) comprising a backing layer inert to the components of the matrix, a self-adhesive matrix containing rotigotine and a protective foil or sheet to be removed prior to use, characterized in that the self-adhesive matrix consists of a solid or semi-solid sem ...


7
Dietrich Wilhelm Schacht, Mike Hannay, Hans Michael Wolff: Transdermal delivery system for the administration of rotigotine. UCB Pharma, August 23, 2012: US20120215185-A1

An improved Transdermal Delivery System (TDS) comprising a backing layer inert to the components of the matrix, a self-adhesive matrix containing rotigotine and a protective foil or sheet to be removed prior to use,characterized in that the self-adhesive matrix consists of a solid or semi-solid semi ...


8
Schacht Dietrich Wilhelm, Hannay Mike, Wolff Hans Michael: Improved transdermal delivery system for the administration of rotigotine. Sanol Arznei Schwarz, liu weisheng li liantao, September 21, 2005: CN03818425

An improved Transdermal Delivery System (TDS) comprising a backing layer inert to the components of the matrix, a self-adhesive matrix containing rotigotine and a protective foil or sheet to be removed prior to use, characterized in that the self-adhesive matrix consists of a solid or semi-solid sem ...


9
Hannay Mike, Schacht Dietrich Wilhelm, Wolff Hans Michael: Improved transdermal delivery system for the administration of rotigotine. Schwarz Pharma, June 16, 2005: KR1020057001233

An improved Transdermal Delivery System (TDS) comprising a backing layer inert to the components of the matrix, a self-adhesive matrix containing rotigotine and a protective foil or sheet to be removed prior to use, characterized in that the self-adhesive matrix consists of a solid or semi-solid sem ...


10